| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 10/30/2008 | US20080269156 Antisense strand, sense strand are non-phosphorylated at the 5' and 3' termini; pulmonary, eye, microvascular, hearing disorders; target for hypoxia-inducible factor-1 that may regulate hypoxia-induced pathogenesis independent of growth factors such as VEGF |
| 10/30/2008 | US20080269148 Using vector comprising nucleotide sequences which interfere with viral gene expression for prevention and treatment of hepatitis c viral infection; gene expression inhibition |
| 10/30/2008 | US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene |
| 10/30/2008 | US20080269139 FGF-5 Supported and Binding Peptides |
| 10/30/2008 | US20080269128 Albumin Fusion Proteins |
| 10/30/2008 | US20080269127 Albumin Fusion Proteins |
| 10/30/2008 | US20080269126 Albumin Fusion Proteins |
| 10/30/2008 | US20080269125 Albumin Fusion Proteins |
| 10/30/2008 | US20080269113 P53 binding t cell receptor molecules |
| 10/30/2008 | US20080269072 Rational Probe Optimization for Detection of MicroRNAs |
| 10/30/2008 | US20080268519 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 10/30/2008 | US20080268518 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses |
| 10/30/2008 | US20080268516 Catalytic RNA species for use as biosensor and nucleic acid amplification tool |
| 10/30/2008 | US20080268509 Methods of labeling polynucleotides with energy transfer dyes |
| 10/30/2008 | US20080268508 Enriching, isolating, separating and/or purifying targeted nucleic acid molecule (bacterial mRNA) from sample through selective full-length reverse transcription |
| 10/30/2008 | US20080268507 Recombinant Dna Nicking Endonuclease and Uses Thereof |
| 10/30/2008 | US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides |
| 10/30/2008 | US20080268489 Therapeutic polypeptide for use in treatment of heart, hypothermic and cardiovascular disorders |
| 10/30/2008 | US20080268462 Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits |
| 10/30/2008 | US20080268457 siRNA targeting forkhead box P3 (FOXP3) |
| 10/30/2008 | US20080268454 Compositions, methods and systems for inferring bovine breed or trait |
| 10/30/2008 | US20080268453 Types of lymphoma and method for prognosis thereof |
| 10/30/2008 | US20080268438 Model system for identifying anti-cancer agents |
| 10/30/2008 | US20080268436 Schizophrenia, Schizoaffective Disorder and Bipolar Disorder Susceptibility Gene Mutation and Applications to Their Diagnosis and Treatment |
| 10/30/2008 | US20080268432 Method for detection of staphylococcus epidermidis |
| 10/30/2008 | US20080268431 Encapsulating within double layer metal hydroxide; electrophoresis |
| 10/30/2008 | US20080268428 Chromosome 5 Genetic Variants Related to Dyslexia |
| 10/30/2008 | US20080268068 methods and kits for determining the presence or absence of a SPARC promoter mutation indicative of a cancer's resistance or sensitivity to a therapeutic regimen |
| 10/30/2008 | US20080267987 Major histocompatibility complex polypeptide for use in targeting, detecting and purifying antigen-specific T-cells; for treatment and prevention of inflammatory, arthritic and autoimmune disease |
| 10/30/2008 | US20080267985 Major allergen Phl p 1 comprising reduced immunoglobulin reactivity for use in treating grass pollen allergies; immunotherapy |
| 10/30/2008 | US20080267980 Complement Receptor 2 Targeted Complement Modulators |
| 10/30/2008 | US20080267974 Tumor necrosis factor specific immunoglobulin for use in diagnosis and treatment of autoimmune diseases |
| 10/30/2008 | US20080267973 Diagnosis and Treatment of Siglec-6 Associated Diseases |
| 10/30/2008 | US20080267966 Polypeptides from Non-Typeable Haemophilus Influenzae |
| 10/30/2008 | US20080267962 Albumin Fusion Proteins |
| 10/30/2008 | US20080267949 Peptides capable of binding to serum proteins |
| 10/30/2008 | US20080267931 Compositions for Silencing the Expression of Vdac1 and Uses Thereof |
| 10/30/2008 | US20080267910 Nucleotide sequences coding interleukin-21/22 for use in identifying modulators for prevention and treatment of viral infection and cell proliferative disorders |
| 10/30/2008 | US20080267872 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization |
| 10/30/2008 | US20080267871 Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide |
| 10/30/2008 | US20080267863 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer |
| 10/30/2008 | US20080265206 Enzymatic conversion of 5-norbornene-2-carbonitrile to give 5-norbornene-2-carboxylic acid with a high substrate concentration; nucleic acid encoding said polypeptide; suitable for preparation of cyclic olefin copolymers, pharmaceutical intermediates, pesticides or fragrances |
| 10/30/2008 | CA2684570A1 Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria |
| 10/29/2008 | EP1985705A2 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 10/29/2008 | EP1985702A2 CPG-like nucleic acids and methods of use thereof |
| 10/29/2008 | EP1984546A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects |
| 10/29/2008 | EP1984499A2 Oligomeric compounds and compositions for the use in modulation of micrornas |
| 10/29/2008 | EP1984383A2 Methods of extracting rna |
| 10/29/2008 | EP1984381A2 6-modified bicyclic nucleic acid analogs |
| 10/29/2008 | EP1984011A2 Igf-ir antagonists as adjuvants for treatment of prostate cancer |
| 10/29/2008 | EP1934378A4 Methods for diagnosing pancreatic cancer |
| 10/29/2008 | EP1841777A4 Oligonucleotides derived from mycobacterium for stimulating immune function, treating immune-related diseases, atopic dermatitis and/or protecting normal immune cell |
| 10/29/2008 | EP1725574A4 Thrombomodulin (thbd) haplotypes predict outcome of patients |
| 10/29/2008 | EP1568705B1 Method and apparatus for concentration and purification of nucleic acid |
| 10/29/2008 | EP1485502B1 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof |
| 10/29/2008 | EP1366192B8 Direct multiplex characterization of genomic dna |
| 10/29/2008 | EP0961831B1 Human endokine alpha |
| 10/29/2008 | CN101296935A Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 10/29/2008 | CN101296702A Compositions and methods for the diagnosis and therapy of BCL2-associated cancers |
| 10/29/2008 | CN101294162A P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 10/29/2008 | CN101293909A Nucleic acid bionic nano material with electric potential gradient, preparation method and application thereof |
| 10/29/2008 | CN101293908A Modified oligonucleotides for telomerase inhibition |
| 10/29/2008 | CN100429320C Plasma or serum marker and process for detection of cancer |
| 10/28/2008 | USRE40557 The method of the invention for labeling nucleotides comprises the steps of: reacting a reactive moiety of a linker, which linker is a platinum compound having a stabilizing bridge and two reactive moieties, with an electron donating moiety of a spacer, which spacer comprises a chain having at least four |
| 10/28/2008 | US7442855 naturally-occurring and recombinant nucleic acids encoding cyclotides characterized by activity against plant pathogens |
| 10/28/2008 | US7442788 Nucleosides; peptide nucleic acids; orientation of sugar governs positioning of antisense molecule |
| 10/28/2008 | US7442786 Comprises nucleotide sequences coding heterologous protein and tissue specific regulatory sequeces for use in controlling cell wall and lignin development; gene expression inhibition |
| 10/28/2008 | US7442784 For regulation of gene expression |
| 10/28/2008 | US7442783 Natural IgM antibodies and inhibitors thereof |
| 10/28/2008 | US7442782 Intron associated with myotonic dystrophy type 2 and methods of use |
| 10/28/2008 | US7442781 Diagnosis, prevention and treatment of cancer |
| 10/28/2008 | US7442778 Modified Fc molecules |
| 10/28/2008 | US7442768 amino acid sequences that can be used as in vivo fluorescent markers which can be expressed in host cells in in vitro cultures using mammal cells |
| 10/28/2008 | US7442767 α1D calcium channel expressed in atrium |
| 10/28/2008 | US7442688 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation |
| 10/28/2008 | US7442685 DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia |
| 10/28/2008 | US7442551 Lentiviral packaging constructs |
| 10/28/2008 | US7442544 Viral vector in which gene for Sendai viral protein selected from NP, P, and L proteins is deleted or inactivated while all other gene functions are retained; use as expression vector in e.g. gene therapy; efficient system for reconstituting Sendai virus |
| 10/28/2008 | US7442536 proteins is "cysteinized" to permit easier conjugation to a targeting moiety |
| 10/28/2008 | US7442535 Fusion protein incorporating a cysteinized ribonuclease |
| 10/28/2008 | US7442532 Essential fungal CaYLR100w polypeptides, and methods of use |
| 10/28/2008 | US7442523 Nucleotide sequences coding bacterial surface protein for use in development of vaccines and prevention of infection |
| 10/28/2008 | US7442520 modulator of tumor growth and metastasis in certain cancer types, especially breast and lung cancer |
| 10/28/2008 | US7442519 KCNQ2-15 potassium channel |
| 10/28/2008 | US7442510 identifying molecular beacons in which a secondary structure prediction algorithm is employed to identify oligonucleotide sequences within a target gene having the requisite hairpin structure |
| 10/28/2008 | US7442509 predicting the likelihood that a feline of the breed Maine Coon cat will develop hypertrophic cardiomyopathy; providing a polynucleotide probe capable of hybridizing under stringent conditions to a region within the polynucleotide that encodes MYBPC |
| 10/28/2008 | US7442506 Methods for detection of genetic disorders |
| 10/28/2008 | US7442505 primer set for amplifying a human beta-globin nucleic acid; generating an amplicon; and detecting the presence or absence of the amplicon, wherein the presence of the amplicon of a select human herpesvirus indicates the presence of the select human herpesvirus |
| 10/28/2008 | US7442504 Detecting an elite event EE-GH1 specific region with a primer or probe; amplifying DNA; kits; optimal agronomic performance |
| 10/28/2008 | US7442502 comprises large number of spots of capture material arranged on a base plate by means of an ink jet system, a plurality of types of capture solutions, each said capture material being adapted to specimens |
| 10/28/2008 | US7442500 Diagnosis of diabetes and insulin resistance in humans; obtain adipose cells, extract nucleotide sequences, determine gene expression patterns, evaluate for diabetes and insulin resistance |
| 10/28/2008 | US7442499 Polynucleotides fluorescently labeled, contacted under hybridization conditions with array of different DNA sequences at discrete locations on nonporous surface; fluorescence level of each array sequence is measure of concentration |
| 10/28/2008 | US7442398 Phytase produced from Citrobacter braakii |
| 10/28/2008 | US7442381 Alphavirus replicons and helper constructs |
| 10/28/2008 | US7442379 Recombinant Newcastle disease virus RNA expression systems and vaccines |
| 10/28/2008 | US7442371 Recombinant human albumin-erythropoietin fusion proteins with long-lasting biological effects |
| 10/28/2008 | US7442160 Evolving new molecular function |
| 10/28/2008 | CA2287570C Two-step hybridization and capture of a polynucleotide |
| 10/23/2008 | WO2008128233A1 Methods and compositions concerning the vegfr-2 gene (kinase domain receptor, kdr) |
| 10/23/2008 | WO2008128176A1 Influenza polynucleotides, expression constructs, compositions, and methods of use |